deltatrials
Completed PHASE3 NCT00150943

Stenting in Renal Dysfunction Caused by Atherosclerotic Renal Artery Stenosis

The Benefit of STent Placement and Blood Pressure and Lipid-Lowering for the Prevention of Progression of Renal Dysfunction Caused by Atherosclerotic Ostial Stenosis of the Renal Artery (STAR)

Sponsor: UMC Utrecht

Conditions Kidney Failure Renal Artery Obstruction
Interventions Renal artery stent
Updated 5 times since 2017 Last updated: Apr 26, 2006 Started: Jun 30, 2000

A PHASE3 clinical study on Kidney Failure and Renal Artery Obstruction, this trial is completed. The trial is conducted by UMC Utrecht and has accumulated 5 data snapshots since 2000. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE3

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE3

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE3

    First recorded

Jun 2000

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • UMC Utrecht
Data source: UMC Utrecht

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Utrecht, Netherlands